Genetic and epigenetic factors contribute to the onset of preeclampsia

https://doi.org/10.1016/j.mce.2007.11.022Get rights and content

Abstract

Preeclampsia (PE) is a major cause of perinatal materno-foetal morbidity and pregnancy-associated-mortality in industrialized countries. Clinically, PE associates maternal pregnancy-induced hypertension with proteinuria. PE is often considered as a two-stage disease. The first stage is a shallow cytotrophoblastic invasion which induces cycles of hypoxia-reoxygenation at the placental level. Subsequently an abnormal expression pattern occurs and is followed by the release of soluble factors and trophoblastic debris in the maternal blood flow. These stimuli trigger the second phase of the disease, the maternal syndrome. Although some molecular actors have been recently identified, mechanisms of the disease onset remains poorly understood. It seems that combinations of genetic, epigenetic and environmental factors are involved. Here, we suggest that epigenetic marks have to be considered to decipher the physiopathological process of PE. Since these marks must be established early and are traceable in the maternal blood flow, they could constitute a diagnosis tool.

Introduction

At the blastocyst stage, the human embryo is anchored into the uterine wall during the implantation process. From then on, a part of the extra-embryonic tissues invades the endometrium, which leads to the formation of a placenta. The placenta is a transient organ essential for maintaining pregnancy and ensuring embryonic and foetal growth. Indeed, this organ is crucial for adequately establishing an immunological tolerance to the embryo, similar to a hemi-allogenic graft, for the secretion of hormones, and for nutrients and gas exchanges. Placentation is a multi-step process where the maternal endometrium must first undergo a decidualization, characterized by structural and biochemical modifications. Then, interactions between the trophoblasts, which are the principal cell type of the placenta, and decidual components lead to implantation sensu stricto. Finally, trophoblastic cells invade the decidua and restructure the uterine vascular system to increase the vascular flow at the utero-placental interface. This ultimate human-specific step leads to the formation of a hemochorial placenta at the end of the first trimester. Alterations of any event in this sequence may lead to obstetrical complications for the mother and/or the foetus. The main placental diseases are preeclampsia (PE) and intra-uterine growth restriction (IUGR).

Clinically, PE associates maternal pregnancy-induced hypertension (>140/90 mmHg) with proteinuria (>0.3 g a day), and in the majority of cases, mild to severe oedema. This syndrome affects up to 10% of the pregnancies (Sibai et al., 1997, Witlin and Sibai, 1998, Cecil et al., 2004). It is the major cause of perinatal materno-foetal morbidity and remains the main cause of pregnancy-associated-mortality in industrialized countries (Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, 2000). Indeed, this multisystemic disease can lead to severe clinical conditions, such as HELLP (Haemolysis, Elevated Liver enzymes and Low Platelets) when a haemolytic process is observed and more rarely to eclampsia, when generalised seizures appear. Both threaten the life of the mother. The only way to resolve the symptoms is the delivery of the placenta. Thus, extraction of the foetus before normal term is the classical treatment for PE, leading to iatrogenic prematurity. Furthermore, in over 25% of the cases, PE induces IUGR, a condition defined by a rupture of the foetal growth curve, leading generally to low weight newborns, according to a given cut-off (Battaglia, 1967, Breart et al., 1982, Seeds and Peng, 1998, Ergaz et al., 2005). Consequently, PE indirectly contributes to the risk of developing the metabolic syndrome (a condition associated with low weight at birth characterized by obesity, type II diabetes, and cardiovascular disease at adult age (Barker et al., 1989)). PE is a real medical challenge since women suffering PE typically develop clinical signs and symptoms from mid-gestation (after 20 weeks of pregnancy), when it is too late to efficiently treat and limit the disease. Although the disease appears late, it is now widely recognized that the physiopathological process starts as early as the end of the first trimester of pregnancy. In PE, a shallow trophoblastic invasion of the spiral uterine arteries leads to the maintenance of their contractile properties and to the increase of the vascular resistance (Gerretsen et al., 1981, Kaufmann et al., 2003, Fisher, 2004). This defective invasion triggers a cascade of events that eventually leads to the appearance of the clinical signs (Roberts and Lain, 2002, Redman and Sargent, 2005, Roberts and Gammill, 2005). Research about PE has been extensive during the last decade, but significant improvements in early prediction or diagnosis of the disorder are still awaited. Nevertheless several physiopathological pathways have been elucidated in PE, with the identification of master factors, such as sFlt-1 (soluble Fms-like tyrosine kinase 1, Maynard et al., 2003) and endoglin (Venkatesha et al., 2006), two proteins influencing angiogenesis and vasculogenesis, and STOX1 (Storkhead-box protein 1) a transcriptional factor that seems to genetically predispose to PE in Dutch families (van Dijk et al., 2005). However, PE aetiology remains poorly understood since the disease is heterogeneous, multi-factorial and widely differs in women according to specific risk factors (Duckitt and Harrington, 2005) (primiparity, age of the mother, smoking habits, previous hypertension, familial history of gravidic hypertension, etc.). This review provides an overview of the current theories and emerging perspectives in the field of elucidating the physiopathological process of PE, focusing in particular on putative epigenetic signatures characterizing the pathological placentas.

Section snippets

Placentation process

During implantation the undifferentiated mononuclear trophoblast cells reside in two different types of highly specialized chorionic villi, the floating villi that float in maternal blood and anchoring villi present within the uterine wall that attach the fetus to the mother (cf. Fig. 1). These highly proliferative, undifferentiated trophoblast cells follow two separate pathways of differentiation (Cross et al., 1994). In floating villi, they have the unique ability to fuse and form the

The onset of preeclampsia

PE is commonly considered as a two-stages disease (Roberts and Gammill, 2005). The first stage relates to a partial failure of early trophoblast invasion and remodelling of the spiral arteries. Consequently, the vascular flow is restricted in PE placentas, and the insufficient blood supply to the placenta causes hypoxia. Ultimately, ischemic lesions induced by the oxidative stress appear (Granger et al., 2002, Gupta et al., 2005). The second stage is the maternal syndrome, which is

Genetic causes of preeclampsia

The molecular processes that cause poor placentation are more controversial and uncertain. It seems acceptable to think that any molecular anomalies that reduce the invasive capacity of EVCT could trigger PE and that factors involved in maternal response to placental defects are fundamental. Thus, the possibility of a genetic predisposition to PE has been considered. Indeed, frequency and severity of the disease are substantially higher in women with pre-existing maternal hypertension,

Acknowledgements

STC is a PhD student receiving a fellowship from the French Ministry of Research. English corrections by Ilies Kamoun are greatly acknowledged.

References (100)

  • H. He et al.

    Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

    J. Biol. Chem.

    (1999)
  • C.A. Hubel et al.

    Lipid peroxidation in pregnancy: new perspectives on preeclampsia

    Am. J. Obstet. Gynecol.

    (1989)
  • T.H. Hung et al.

    Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia

    Taiwan J. Obstet. Gynecol.

    (2006)
  • E. Jauniaux et al.

    Physiological implications of the materno-fetal oxygen gradient in human early pregnancy

    Reprod. Biomed. Online

    (2003)
  • X. Jeunemaitre et al.

    Haplotypes of angiotensinogen in essential hypertension

    Am. J. Hum. Genet.

    (1997)
  • J.C. Kingdom et al.

    Oxygen and placental villous development: origins of fetal hypoxia

    Placenta

    (1997)
  • M. Kolben et al.

    Proteases and their inhibitors are indicative in gestational disease

    Eur. J. Obstet. Gynecol. Reprod. Biol.

    (1996)
  • G. Liang et al.

    DNA methylation differences associated with tumor tissues identified by genome scanning analysis

    Genomics

    (1998)
  • F. Lyall

    Priming and remodelling of human placental bed spiral arteries during pregnancy—a review

    Placenta

    (2005)
  • L.M. Matrisian

    Metalloproteinases and their inhibitors in matrix remodeling

    Trends Genet.

    (1990)
  • T. Nakajima et al.

    Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations

    Am. J. Hum. Genet.

    (2002)
  • R.B. Ness et al.

    Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia

    Am. J. Obstet. Gynecol.

    (2006)
  • P.A. Patston et al.

    Significance of secondary structure predictions on the reactive center loop region of serpins: a model for the folding of serpins into a metastable state

    FEBS Lett.

    (1996)
  • C.W. Redman et al.

    Placental debris, oxidative stress and pre-eclampsia

    Placenta

    (2000)
  • C.W. Redman et al.

    Preeclampsia and the systemic inflammatory response

    Semin. Nephrol.

    (2004)
  • J.M. Roberts et al.

    Recent insights into the pathogenesis of pre-eclampsia

    Placenta

    (2002)
  • I.L. Sargent et al.

    NK cells and human pregnancy—an inflammatory view

    Trends Immunol.

    (2006)
  • J.W. Seeds et al.

    Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard?

    Am. J. Obstet. Gynecol.

    (1998)
  • E. Shibata et al.

    Enhancement of mitochondrial oxidative stress and up-regulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae

    Placenta

    (2003)
  • B.M. Sibai et al.

    Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group

    Am. J. Obstet. Gynecol.

    (1997)
  • G.A. Silverman et al.

    The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

    J. Biol. Chem.

    (2001)
  • G.R. Verwoerd et al.

    Primipaternity and duration of exposure to sperm antigens as risk factors for pre-eclampsia

    Int. J. Gynaecol. Obstet.

    (2002)
  • J.X. Wang et al.

    Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia

    Lancet

    (2002)
  • Y. Wang et al.

    Placental mitochondria as a source of oxidative stress in pre-eclampsia

    Placenta

    (1998)
  • Y. Zhou et al.

    Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia

    J. Reprod. Immunol.

    (1998)
  • D.M. Adelman et al.

    Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses

    Genes Dev.

    (2000)
  • Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, 2000....
  • R. Arngrimsson et al.

    A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13

    Hum. Mol. Genet.

    (1999)
  • D.J. Barker et al.

    The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis

    J. Epidemiol. Community Health

    (1989)
  • J.S. Barros et al.

    Human chorionic gonadotropin in human placentas from normal and preeclamptic pregnancies

    Arch. Gynecol. Obstet.

    (2002)
  • P. Bischof et al.

    Paracrine and autocrine regulators of trophoblast invasion—a review

    Placenta

    (2000)
  • G. Breart et al.

    Risk of fetal growth retardation as a result of maternal hypertension. Preparation to a trial on antihypertensive drugs

    Dev. Pharmacol. Ther.

    (1982)
  • D.D. Carson et al.

    Mucin and proteoglycan functions in embryo implantation

    Bioessays

    (1998)
  • R.L. Cecil et al.

    Cecil Textbook of Medicine

    (2004)
  • S. Chappell et al.

    Searching for genetic clues to the causes of pre-eclampsia

    Clin. Sci. (Lond.)

    (2006)
  • S.T. Chelbi et al.

    Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia

    Hypertension

    (2007)
  • S. Cnattingius et al.

    Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study

    Am. J. Med. Genet. A

    (2004)
  • M. Cohen et al.

    Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells

    Mol. Hum. Reprod.

    (2006)
  • K.D. Cowden Dahl et al.

    Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation

    Mol. Cell. Biol.

    (2005)
  • J.C. Cross et al.

    Implantation and the placenta: key pieces of the development puzzle

    Science

    (1994)
  • Cited by (100)

    • MiR-141-3p downregulation promotes tube formation, migration, invasion and inhibits apoptosis in hypoxia-induced human umbilical vein endothelial cells by targeting Notch2

      2021, Reproductive Biology
      Citation Excerpt :

      The results suggested that silencing Notch2 counteracted the inhibitory effect of miR-141-3p inhibitor on the apoptosis of hypoxia-induced HUVECs. The pathogenesis of PE is attributed to multifarious elements including genetic factors, nutritional factors, immune dysfunction, ischemia and hypoxia in placental trophoblast cells, and endothelial cell injury [16–18]. The malfunction of trophoblast cells and endothelial cells plays important roles in the development of PE.

    • Genetic Factors in the Etiology of Preeclampsia/Eclampsia

      2021, Chesley’s Hypertensive Disorders in Pregnancy
    View all citing articles on Scopus
    View full text